Bourne Partners Strategic Capital and Meeting Street Capital Lead Series A in Cadence Rx

October 29, 2020

Bourne Partners Strategic Capital (BPSC) and Meeting Street Capital (MSC) jointly led a Series A growth equity investment in Cadence Rx, a workers' compensation-focused pharmacy benefit manager (PBM) founded by Artemis Emslie. The funding will support scaling Cadence Rx's tech-enabled PBM platform to reduce drug spend and expand program management for workers' compensation carriers, third-party administrators, self-insured employers and state-run enterprises.

Buyers
Bourne Partners Strategic Capital, Meeting Street Capital
Targets
Cadence Rx
Location
Florida, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.